Torigen Pharmaceuticals

1 follower


Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.

Employees

11-50

Links

Org chart

Ashley Kalinauskas

Collapse
Mark Suckow
Chief Technology Officer
Michael Lucroy
Chief Medical Officer
Ryan Clauson
VP of Research & Development
Sean Fitzgerald
VP of Market Development
Chelsea Greenberg
Vice President of Veterinary Affairs
Christine McCoy
External Innovation & Clinical Trial Manager
John Kallassy
Executive Advisor
Kathryn Deeley
Quality Manager
Troy Gobbett, PMP
Vice President of Operational Excellence